SUNDAY, MAY 20, 2018

Reps. Crenshaw, Meeks congratulate Nobel Prize scientists

Reps. Crenshaw, Meeks congratulate Nobel Prize scientists.
Reps. Crenshaw, Meeks congratulate Nobel Prize scientists. | Courtesy of
U.S. Reps. Ander Crenshaw (R–FL) and Gregory Meeks (D–NY), co-chairs of Congressional Caucus on Malaria and Neglected Tropical Diseases, recently congratulated Nobel Prize scientists for their progress against malaria and parasitic diseases.

Three scientists won the Nobel Prize in 2015. Their research fueled new drugs, which have saved millions of people from malaria and three other kinds of parasitic diseases.

“We congratulate William C. Campbell and Satoshi Omura for their discovery of Ivermectin, a medicine that has nearly eradicated river blindness and dramatically reduced the incidence of lymphatic filariasis,” the congress said. “We also congratulate Tu Youyou for her discovery of Artemisinin, a drug that has significantly reduced malaria mortality rates.”

New drugs for malaria and other tropical diseases make a notable impact on people’s lives.

“The U.S. Government, through the President’s Malaria Initiative and other critical initiatives, has played an instrumental role in the progress of efforts to eradicate malaria and NTDs globally," the congress said. "In the years to come, we remain committed to supporting the highly cost-effective and impactful work of controlling and eliminating the threat of malaria and parasitic diseases.”

Crenshaw has represented the state of Florida in the United States House since 2001. Born in Jacksonville, Florida, in 1944, he previously served as a member of the Florida Senate from 1986-1994. He was educated at the University of Georgia and University of Florida and is single. He serves on the following committees: Appropriations.

Organizations in this Story

U.S. Representative Ander Crenshaw (FL-4)

Want to get notified whenever we write about U.S. Representative Ander Crenshaw (FL-4) ?
Next time we write about U.S. Representative Ander Crenshaw (FL-4), we'll email you a link to the story. You may edit your settings or unsubscribe at any time.